Enzymotec Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 235

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $290M

Enzymotec General Information

Description

Producer and seller of lipid-based bioactive ingredients created to offer medical foods based on sophisticated processes and technologies. The company's lipid-based bioactive ingredients are used in a wide range of products, including a drugs for reducing cholesterol and the treatment of attention disorders and slowing cognitive degeneration in adults, as well as nutritional supplements, enabling the nutritional supplement, healthcare, medical foods and infant formula industries avail advanced products in order to produce infant food and nutritional supplements.

Contact Information

Website
www.enzymotec.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • P.O. Box 6
  • Migdal Haemek 2310001
  • Israel
Primary Industry
Other Consumer Non-Durables
Acquirer
NovaTaste
Corporate Office
  • P.O. Box 6
  • Migdal Haemek 2310001
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enzymotec Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 20-Dec-2017 $290M Completed Profitable
8. Secondary Transaction - Open Market 24-Aug-2017 Completed Profitable
7. Secondary Transaction - Open Market 09-Feb-2016 Completed Profitable
6. Secondary Transaction - Open Market 05-Mar-2014 Completed Profitable
5. IPO 27-Sep-2013 Completed Profitable
4. PE Growth/Expansion Completed Generating Revenue
3. Early Stage VC (Series B1) 02-Feb-2009 Completed Generating Revenue
2. Early Stage VC 20-Jun-2001 $2M $3M Completed Product Development
1. Early Stage VC 01-Jan-2000 $1M $1M Completed Product Development
To view Enzymotec’s complete valuation and funding history, request access »

Enzymotec Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Producer and seller of lipid-based bioactive ingredients created to offer medical foods based on sophisticated processes
Other Consumer Non-Durables
Migdal Haemek, Israel
235 As of 2017

Hauppauge, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enzymotec Competitors (1)

One of Enzymotec’s competitors is Rochem International, a Corporation company based in Hauppauge, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Rochem International Corporation Hauppauge, NY
You’re viewing 1 of 1 competitors. Get the full list »

Enzymotec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enzymotec Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arancia Corporation Minority
Galam Corporation Minority
GlenRock Israel Growth/Expansion Minority
Israel Secondary Fund (ISF) Secondary Buyer Minority
Millennium Materials Technologies Fund Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Enzymotec Investments (2)

Enzymotec’s most recent deal was a Corporate Asset Purchase with Enzymotec (Rights to Five Nutritional Products). The deal was made on 30-Aug-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Enzymotec (Rights to Five Nutritional Products) 30-Aug-2017 Corporate Asset Purchase Buildings and Property
Advanced Lipids 26-Jun-2007 Joint Venture Food Products
To view Enzymotec’s complete investments history, request access »

Ready to get started?

Request a free trial

Enzymotec FAQs

  • When was Enzymotec founded?

    Enzymotec was founded in 1998.

  • Where is Enzymotec headquartered?

    Enzymotec is headquartered in Migdal Haemek, Israel.

  • What is the size of Enzymotec?

    Enzymotec has 235 total employees.

  • What industry is Enzymotec in?

    Enzymotec’s primary industry is Other Consumer Non-Durables.

  • Is Enzymotec a private or public company?

    Enzymotec is a Private company.

  • What is the current valuation of Enzymotec?

    The current valuation of Enzymotec is .

  • What is Enzymotec’s current revenue?

    The current revenue for Enzymotec is .

  • How much funding has Enzymotec raised over time?

    Enzymotec has raised $76M.

  • Who are Enzymotec’s investors?

    Arancia, Galam, GlenRock Israel, Israel Secondary Fund (ISF), and Millennium Materials Technologies Fund are 5 of 9 investors who have invested in Enzymotec.

  • Who are Enzymotec’s competitors?

    Rochem International is a competitor of Enzymotec.

  • When was Enzymotec acquired?

    Enzymotec was acquired on 20-Dec-2017.

  • Who acquired Enzymotec?

    Enzymotec was acquired by NovaTaste.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process